This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
YS Biopharma Co., Ltd.
Q42023
7/26/2023
Operator
Conference Operator
Ladies and gentlemen, thank you for standing by and welcome to YS Biopharma's fiscal year 2023 earnings call. At this time, all participants are in a listen-only mode. After the management's prepared remarks, we will have a question and answer session. Please note that this event is being recorded. Now I'd like to hand the conference over to your speaker host today, Ms. Alyssa Lee, the company's investor relations director. Please go ahead, ma'am.
Ms. Brenda Wu
Chief Financial Officer
Thank you very much. To begin today, I would like to hand the call over to our founder and chairman, Mr. Yi Zhang, who will give some brief remarks in Chinese. I will then translate these remarks into English. Mr. Yi Zhang, please speak.
Mr. Yi Zhang
Founder and Chairman
Hello, everyone, and thank you for joining us today.
You're reading a preview of the YS Q4 2023 earnings call.
Free account.
Disclaimer